As GLP-1 medications have quietly reshaped how millions of people manage weight and diabetes, a new study introduces a sobering counterpoint: the same mechanism that makes these drugs effective may impair the body's absorption of vitamin B12, potentially opening a pathway to rare but serious neurological harm. The finding does not unravel the promise of these treatments, but it reminds us that when medicine reaches into the body's deepest systems, the consequences — intended and otherwise — rarely stay contained. The question now is not whether to trust these drugs, but how to wield them with
Study Links GLP-1 Weight Loss Drugs to Rare Brain Disorder Risk
Patients taking GLP-1 medications face potential risk of rare neurological disorder that could cause serious neurological complications.